Single-nucleotide polymorphism in the E-cadherin gene promoter modifies the risk of prostate cancer

被引:56
|
作者
Verhage, BAJ
van Houwelingen, K
Ruijter, TEG
Kiemeney, LA
Schalken, JA
机构
[1] Univ Nijmegen, Med Ctr, Dept Epidemiol, NL-6500 HB Nijmegen, Netherlands
[2] Univ Nijmegen, Med Ctr, Dept Urol, NL-6500 HB Nijmegen, Netherlands
[3] Univ Nijmegen, Med Ctr, Dept Pathol, NL-6500 HB Nijmegen, Netherlands
关键词
prostate cancer; E-cadherin; promoter; single-nucleotide polymorphism; hereditary;
D O I
10.1002/ijc.10541
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
E-cadherin plays a major role in intercellular adhesion, cell polarity and tissue architecture. We determined the relative risk of PCa associated with a previously reported C/A SN P at -160 bp relative to the transcription-start site of the E-cadherin gene promoter. Eighty-two PCa patients and 188 controls were genotyped. Genotype and allele frequencies differed significantly among cases and controls. A-allele carriers had a higher relative risk of PCa (OR = 3.6, 95% CI 2.0-6.4) compared to C-only carriers. AC and AA genotypes had an increased risk of PCa (OR = 3.8, 95% CI 2.1-6.8 and OR = 1.7, 95% CI 0.4-6.6, respectively) compared to CC genotypes. (C) 2002 Wiley-Liss, Inc.
引用
收藏
页码:683 / 685
页数:3
相关论文
共 50 条
  • [21] E-cadherin Polymorphisms and haplotypes influence risk for prostate cancer
    Bonilla, C
    Mason, T
    Long, LR
    Ahaghotu, C
    Chen, WD
    Zhao, AQ
    Coulibaly, A
    Bennett, F
    Aiken, W
    Tullock, T
    Coard, K
    Freeman, V
    Kittles, RA
    PROSTATE, 2006, 66 (05) : 546 - 556
  • [22] A single-nucleotide polymorphism in the TP53 and MDM-2 gene modifies breast cancer risk in an ethnic Arab population
    Alshatwi, Ali A.
    Hasan, Tarique N.
    Shafi, Gowhar
    Alsaif, Mohammed A.
    Al-Hazzani, Amal A.
    Alsaif, Adulaziz A.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2012, 26 (03) : 438 - 443
  • [23] Dual roles of E-cadherin in prostate cancer invasion
    Chunthapong, J
    Seftor, EA
    Khalkhali-Ellis, Z
    Seftor, REB
    Amir, S
    Lubaroff, DM
    Heidger, PM
    Hendrix, MJC
    JOURNAL OF CELLULAR BIOCHEMISTRY, 2004, 91 (04) : 649 - 661
  • [24] Effects of E-cadherin (CDH1) Gene Promoter Polymorphisms on the Risk and Clinicopathological Development of Hepatocellular Carcinoma
    Chien, Ming-Hsien
    Yeh, Kun-Tu
    Li, Yi-Ching
    Hsieh, Yi-Hsien
    Lin, Chien-Huang
    Weng, Meng-Shih
    Kuo, Wu-Hsien
    Yang, Shun-Fa
    JOURNAL OF SURGICAL ONCOLOGY, 2011, 104 (03) : 299 - 304
  • [25] Functional analysis and case-control study of-160C/A polymorphism in the E-cadherin gene promoter:: Association with cancer risk
    Cattaneo, Francesca
    Venesio, Tiziana
    Molatore, Sara
    Russo, Antonio
    Fiocca, Roberto
    Frattini, Milo
    Scovassi, A. Ivana
    Ottini, Laura
    Bertario, Lucio
    Ranzani, Guglielmina Nadia
    ANTICANCER RESEARCH, 2006, 26 (6B) : 4627 - 4632
  • [26] Risk Allele Frequency Analysis and Risk Prediction of Single-Nucleotide Polymorphisms for Prostate Cancer
    Yoon, Byung Woo
    Shin, Hyun-Tae
    Seo, Je Hyun
    GENES, 2022, 13 (11)
  • [27] E-cadherin gene promoter hypermethylation may contribute to the risk of bladder cancer among Asian populations
    Li, Gang
    Liu, Yili
    Yin, Huming
    Zhang, Xuefeng
    Mo, Xiaodong
    Tang, Jing
    Chen, Weiguo
    GENE, 2014, 534 (01) : 48 - 53
  • [28] Comparison study for genotyping of a single-nucleotide polymorphism in the tumor necrosis factor promoter gene
    Juszczynski, P
    Woszczek, G
    Borowiec, M
    Kowalski, M
    Robak, T
    Bilinski, P
    Salles, G
    Warzocha, K
    DIAGNOSTIC MOLECULAR PATHOLOGY, 2002, 11 (04) : 228 - 233
  • [29] The E-cadherin (CDH1)-160 C/A polymorphism and prostate cancer risk: a meta-analysis
    Qiu, Li-Xin
    Li, Ru-Tian
    Zhang, Jian-Bing
    Zhong, Wen-Zhao
    Bai, Jian-Ling
    Liu, Bao-Rui
    Zheng, Ming-Hua
    Qian, Xiao-Ping
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2009, 17 (02) : 244 - 249
  • [30] E-cadherin and associated molecules in the invasion and progression of prostate cancer
    Davies, G
    Jiang, WG
    Mason, MD
    ONCOLOGY REPORTS, 1998, 5 (06) : 1567 - 1576